A big deal in biotech is going to line the pockets of some of Wall Street’s biggest firms. The biotech company Thermo Fisher Scientific has agreed to buy the drug-ingredients maker Patheon in a $7.2 billion deal. In a statement Monday, Thermo Fisher said it would acquire all outstanding Patheon shares for $35 apiece in cash, 35%
[Read More …]
Creating Wealth Without Risk - You’ll Get A Proven System For Profiting 16%, 18%, 24% Up To 50% Guaranteed By Law With Safe, Certain, And High-yielding Tax Lien Certificates
via Tumblr Some Of Wall Street’s Biggest Firms Just Landed A Big Pay Day
Write something about yourself. No need to be fancy, just an overview.